BioSpecifics Technologies Corp.  

(Public, NASDAQ:BSTC)   Watch this stock  
Find more results for Marc Guitman�
-0.77 (-1.94%)
Feb 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 38.62 - 39.90
52 week 22.23 - 42.00
Open 39.48
Vol / Avg. 0.00/27,906.00
Mkt cap 253.27M
P/E 61.04
Div/yield     -
EPS 0.64
Shares 6.50M
Beta 1.08
Inst. own 59%
Mar 9, 2015
Biospecifics Technologies Corp at ROTH Conference - 8:30PM EDT - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 34.76% 36.54%
Operating margin 52.89% 54.91%
EBITD margin - 55.36%
Return on average assets 21.48% 25.39%
Return on average equity 22.21% 26.57%
Employees 5 -
CDP Score - -


United States - Map
+1-516-5937000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


BioSpecifics Technologies Corp. (BioSpecifics) is a biopharmaceutical company involved in the development of an injectable collagenase for multiple indications. The Company has a development and license agreement with Auxilium Pharmaceuticals, Inc. (Auxilium) for injectable collagenase (which Auxilium has named XIAFLEX) for clinical indications in Dupuytren�s contracture, Peyronie�s disease and frozen shoulder (adhesive capsulitis), and Auxilium has an option to acquire additional indications that it may pursue, including lipomas and cellulite. Auxilium has an agreement with Pfizer, Inc. (Pfizer), pursuant to which Pfizer has the right to market XIAFLEX for Dupuytren�s contracture and Peyronie�s disease in 27 member countries of the European Union and 19 other European and Eurasian countries, and under the registered trademark XIAPEX (collagenase clostridium histolyticum).

Officers and directors

Thomas L. Wegman President, Principal Executive Officer, Principal Financial Officer, Director
Age: 59
Bio & Compensation  - Reuters
Mark N. Wegman Ph.D. Director
Age: 64
Bio & Compensation  - Reuters
Toby Wegman Director
Age: 79
Bio & Compensation  - Reuters
Paul A. Gitman M.D. Independent Director
Age: 73
Bio & Compensation  - Reuters
George M. Gould J.D. Independent Director
Age: 76
Bio & Compensation  - Reuters
Michael Schamroth Independent Director
Age: 74
Bio & Compensation  - Reuters